Business Standard

Top headlines: Amazon battles regulators, e-way bill generation grows

Business Standard brings you the top headlines on Wednesday

Amazon, e-commerce, online shopping
Premium

BS Web Team New Delhi
Top headlines of the hour: Cipla gets DCGI nod to import Moderna vaccine, E-way bill generation picks up pace in June, Amazon battles regulators in bid to stay dominant in India

Cipla gets DCGI nod to import Moderna vaccine; no commercial deal yet

India on Tuesday approved a fourth Covid-19 vaccine--Moderna’s mRNA-1273. With this, the government has cleared the path for importing Covid vaccines approved by international regulators, without bridging clinical studies.

Cipla is supporting Moderna with the regulatory approval for import the vaccines to be donated to India, a company spokesperson said. The vaccine developed by Cambridge (Massachusetts)-based

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in